Breast cancer metastasis: markers and models
The DOI matches its Crossref record; 115 of the 115 references it cites were found in a registry or an index.
Abstract
Breast cancer starts as a local disease, but it can metastasize to the lymph nodes and distant organs. At primary diagnosis, prognostic markers are used to assess whether the transition to systemic disease is likely to have occurred. The prevailing model of metastasis reflects this view--it suggests that metastatic capacity is a late, acquired event in tumorigenesis. Others have proposed the idea that breast cancer is intrinsically a systemic disease. New molecular technologies, such as DNA microarrays, support the idea that metastatic capacity might be an inherent feature of breast tumours. These data have important implications for prognosis prediction and our understanding of metastasis.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Immune cells were shown to both enhance and inhibit malignant cells proliferation, migration, and metastasis [125-128].”
From Microfluidic modelling of the tumor microenvironment for anti-cancer drug development (2019) · cites this paper as [125]
In the citing paper
“Chemical gradients play an important role in tumor cell invasion of metastatic cancer [195,196] as it significantly directs the migration and differentiation of tumor cells.”
From Microfluidic modelling of the tumor microenvironment for anti-cancer drug development (2019) · cites this paper as [196]
In the citing paper
“Metastasis is the leading cause of death from breast cancer1, 37-39.”
From Liposomal Formulation of HIF-1α Inhibitor Echinomycin Eliminates Established Metastases of Triple-negative Breast Cancer (2020) · cites this paper as [1]
Citations
Cites
Molecular portraits of human breast tumours
Perou, C. M., Sørlie, T., Eisen, M. B., van de Rijn, M., Jeffrey, S. S., Rees, C. A., Pollack, J. R., Ross, D. T., Johnsen, H., Akslen, L. A., et al. (2000) · Nature · doi:10.1038/35021093 · Cited by 16,261
Cluster analysis and display of genome-wide expression patterns
Eisen, M. B., Spellman, P. T., Brown, P. O., & Botstein, D. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.25.14863 · Cited by 16,184
Slamon, D. J., Clark, G. M., Wong, S. G., Levin, W. J., Ullrich, A., & McGuire, W. L. (1987) · Science · doi:10.1126/science.3798106 · Cited by 11,760 · cited 1×
“ERBB2 is overexpressed due to gene amplification in 15–30% of human breast cancer”
Golub, T. R., Slonim, D. K., Tamayo, P., Huard, C., Gaasenbeek, M., Mesirov, J. P., Coller, H., Loh, M. L., Downing, J. R., Caligiuri, M. A., et al. (1999) · Science · doi:10.1126/science.286.5439.531 · Cited by 11,516
Slamon, D. J., Leyland-Jones, B., Shak, S., Fuchs, H., Paton, V., Bajamonde, A., Fleming, T., Eiermann, W., Wolter, J., Pegram, M., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200103153441101 · Cited by 11,500
Sørlie, T., Perou, C. M., Tibshirani, R., Aas, T., Geisler, S., Johnsen, H., Hastie, T., Eisen, M. B., van de Rijn, M., Jeffrey, S. S., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.191367098 · Cited by 10,938
Prospective identification of tumorigenic breast cancer cells
Al-Hajj, M., Wicha, M. S., Benito-Hernandez, A., Morrison, S. J., & Clarke, M. F. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0530291100 · Cited by 10,370
Stem cells, cancer, and cancer stem cells
Reya, T., Morrison, S. J., Clarke, M. F., & Weissman, I. L. (2001) · Nature · doi:10.1038/35102167 · Cited by 9,738
Gene expression profiling predicts clinical outcome of breast cancer
van 't Veer, L. J., Dai, H., van de Vijver, M. J., He, Y. D., Hart, A. A. M., Mao, M., Peterse, H. L., van der Kooy, K., Marton, M. J., Witteveen, A. T., et al. (2002) · Nature · doi:10.1038/415530a · Cited by 9,536
Research works printed but not linked: 2
- Fidler, I. J. Metastasis: quantitative analysis of distribution and fate of tumour embolilabeled with 125 I-5-iodo-2′-deoxyuridine. J. Natl Cancer Inst. 45, 773–782 (1970).
- Leighton, J. Inherent malignancy of cancer cells possibly limited by genetically differing cells in the same tumour. Acta Cytol. 9, 138–140 (1965).
Cited by
Items 901–1,000 of 1,003
Slide-free virtual histochemistry (Part II): detection of field cancerization
You, S., Sun, Y., Chaney, E. J., Zhao, Y., Chen, J., Boppart, S. A., & Tu, H. (2018) · Biomedical Optics Express · doi:10.1364/boe.9.005253 · Cited by 31
Antiproliferative Effect of Trifolium Pratens L. Extract in Human Breast Cancer Cells
Khazaei, M., & Pazhouhi, M. (2018) · Nutrition and Cancer · doi:10.1080/01635581.2018.1521443 · Cited by 31
Li, T., Li, N., Ma, Y., Bai, Y., Xing, C.-M., & Gong, Y. (2019) · Journal of Materials Chemistry B · doi:10.1039/c9tb01649j · Cited by 31
Changes in Biomarker Status in Metastatic Breast Cancer and Their Prognostic Value
Woo, J. W., Chung, Y. R., Ahn, S., Kang, E., Kim, E., Kim, S. H., Kim, J. H., Kim, I. A., & Park, S. Y. (2019) · Journal of Breast Cancer · doi:10.4048/jbc.2019.22.e38 · Cited by 31
Ranđelović, I., Schuster, S., Kapuvári, B., Fossati, G., Steinkühler, C., Mező, G., & Tóvári, J. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20194763 · Cited by 36
Sugimoto, S., Moriyama, R., Mori, T., & Iwasaki, Y. (2015) · Chemical Communications · doi:10.1039/c5cc06211j · Cited by 31
Zhu, H., Gao, F., Li, Y., Jiang, M., Zhang, Y., Chen, K., Han, L., Xue, S., Wang, K., Fan, Q., et al. (2024) · Nano Today · doi:10.1016/j.nantod.2024.102308 · Cited by 31
A polyvalent vaccine for selectively killing tumor-associated bacteria to prevent cancer metastasis
Kang, Z., Chen, L., Li, P., Zheng, Z., Shen, J., Xiao, Z., Yu, M., Yang, Y., & Chen, Q. (2025) · Science Advances · doi:10.1126/sciadv.adt0341 · Cited by 31
“This metastatic journey signifies a transition to a more formidable phase of breast cancer, complicating treatment efforts and dimming the prospects for a favorable outcome ( 3 , 4 ).”
van Winkel, S. L., Peters, J., Janssen, N. N. Y., Kroes, J., Loehrer, E. A., Gommers, J. J. J., Sechopoulos, I., de Munck, L., Teuwen, J., Broeders, M. J. M., et al. (2025) · The Lancet Digital Health · doi:10.1016/j.landig.2025.100882 · Cited by 35
Sun, H., Meng, Q., Tang, S., Su, J., Yin, Q., Chen, L., Gu, W., Yu, H., Zhang, Z., Wang, S., et al. (2015) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.5b00319 · Cited by 30
Microfluidics: Rapid Diagnosis for Breast Cancer
Panesar, S., & Neethirajan, S. R. (2016) · Nano-Micro Letters · doi:10.1007/s40820-015-0079-8 · Cited by 33
Kispert, S. E., Marentette, J., & McHowat, J. (2014) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00218.2014 · Cited by 30
Buranrat, B., Mairuae, N., & Konsue, A. (2017) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2017.03.032 · Cited by 30
SB225002 inhibits prostate cancer invasion and attenuates the expression of BSP, OPN and MMP‑2
Xu, M., Jaing, H., Wang, H., Liu, J., Liu, B., & Guo, Z. (2018) · Oncology Reports · doi:10.3892/or.2018.6504 · Cited by 30
“Metastasis is a major obstacle in cancer therapy; despite constant standardization of chemotherapy or surgical procedures (1,2), some patients die due to distant metastasis of tumor cells.”
Mammographic screening in male patients at high risk for breast cancer: is it worth it?
Marino, M. A., Gucalp, A., Leithner, D., Keating, D. M., Avendaño, D., Bernard‐Davila, B., Morris, E. A., Pinker, K., & Jochelson, M. S. (2019) · Breast Cancer Research and Treatment · doi:10.1007/s10549-019-05338-1 · Cited by 30
Min, Y., Liu, X., Hu, D., Chen, H., Chen, J., Xiang, K., Yin, G., Han, Y., Feng, Y., & Luo, H. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.771226 · Cited by 31
Wang, Q., Karvelsson, S. T., Kotronoulas, A., Guðjónsson, Þ., Halldórsson, S., & Rolfsson, Ó. (2021) · Molecular & Cellular Proteomics · doi:10.1016/j.mcpro.2021.100185 · Cited by 34
Aspirin suppresses breast cancer metastasis to lung by targeting anoikis resistance
Xu, R., Yan, Y., Xu, Z., Zhang, H., Chen, W., Li, H., & Dong, Z. (2021) · Carcinogenesis · doi:10.1093/carcin/bgab117 · Cited by 30
Three-Dimensional in Vitro Models: A Promising Tool To Scale-Up Breast Cancer Research
Azimian, V., Rafiee, L., Sheikholeslam, M., Shariati, L., Vaseghi, G., Savoji, H., & Javanmard, S. H. (2022) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.2c00277 · Cited by 36
Liu, X., Liu, J., Xu, S., Li, X., Wang, Z., Gao, X., Tang, B., & Xu, K. (2023) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.2c10221 · Cited by 30
Samos, J., García-Olmo, D. C., Picazo, M. G., Rubio-Vitaller, A., & García‐Olmo, D. (2006) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1368.022 · Cited by 33
Pal, S., Moulik, S., Dutta, A., & Chatterjee, A. (2014) · Cancer Microenvironment · doi:10.1007/s12307-014-0146-6 · Cited by 30
Zeng, L., Zhong, J., He, G., Li, F., Li, J., Zhou, W. H., Liu, W., Zhang, Y., Huang, S., Liu, Z., et al. (2017) · Journal of Cancer · doi:10.7150/jca.19619 · Cited by 30
Lian, M., & Huang, C. (2018) · Lasers in Medical Science · doi:10.1007/s10103-018-2595-5 · Cited by 30
Karahaliloğlu, Z., Kılıçay, E., Alpaslan, P., Hazer, B., & Denkbaş, E. B. (2017) · Journal of Bioactive and Compatible Polymers · doi:10.1177/0883911517710811 · Cited by 29
Morphometric study of adipocytes on breast cancer by means of photonic microscopy and image analysis
Suárez-Nájera, L. E., Chanona‐Pérez, J. J., Valdivia–Flores, A., Marrero–Rodríguez, D., Salcedo–Vargas, M., García–Ruiz, D. I., & Castro-Reyes, M. A. (2017) · Microscopy Research and Technique · doi:10.1002/jemt.22972 · Cited by 30
Chhabra, A., Chowdhury, A. R., Prabhakar, H., Subramaniam, R., Arora, M. K., Srivastava, A., & Kalaivani, M. (2021) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012968.pub2 · Cited by 36
Chen, D., Yuan, M., Ye, Q., Wang, X., Xu, J., Shi, G.-Y., & Hu, Z. (2020) · Food & Nutrition Research · doi:10.29219/fnr.v64.4240 · Cited by 29
Alsharif, S., Sharma, P., Bursch, K. L., Milliken, R., Lam, V. K., Fallatah, A., Phan, T., Collins, M., Dohlman, P., Tiufekchiev, S., et al. (2021) · Cell Adhesion & Migration · doi:10.1080/19336918.2020.1868694 · Cited by 38
Wu, Y., Ni, H., Yang, D., Niu, Y., Chen, K., Xu, J., Wang, F., Tang, S., Shi, Y., Zhang, H., et al. (2021) · Pathology - Research and Practice · doi:10.1016/j.prp.2021.153551 · Cited by 34
Lu, X., Shen, J., Huang, S., Wang, H., & Liu, D. (2022) · Tissue and Cell · doi:10.1016/j.tice.2022.101802 · Cited by 29
Aljohani, A., Toss, M. S., Elsharawy, K. A., Mirza, S., Ball, G., Green, A. R., & Rakha, E. A. (2022) · PubMed Central · Cited by 29
Zhou, X., Xu, X., Hu, Q., Wu, Y. L., Yu, F., He, C., Qian, Y., Han, Y., Tang, J., & Hu, H. (2022) · Journal of Materials Chemistry B · doi:10.1039/d2tb01855a · Cited by 29
Recent advances in lab-on-a-chip systems for breast cancer metastasis research
Yildirir, B. F., Yalcin-Ozuysal, Ö., & Nonappa, N. (2023) · Nanoscale Advances · doi:10.1039/d2na00823h · Cited by 33
Γιωτοπούλου, Ν., Valiakou, V., Papanikolaou, V., Dubos, S., Athanassiou, E., Tsezou, A., Zacharia, L. C., & Gkretsi, V. (2015) · Clinical & Experimental Metastasis · doi:10.1007/s10585-015-9701-x · Cited by 29
“However, the primary tumor is seldom the cause of death for patients, as 90 % of them die from metastasis [1, 2].”
Gene arrays for diagnosis, prognosis and treatment of breast cancer metastasis
Driouch, K., Landemaine, T., Sin, S., Wang, S., & Lidereau, R. (2007) · Clinical & Experimental Metastasis · doi:10.1007/s10585-007-9110-x · Cited by 29
“The molecular signatures thus better predict the individuals for whom therapy be beneficial and spare unnecessary treatment for over 80% of the others [5, 6, 8, 12 ].”
BackgroundInfluentialZhang, Y., Hong, H., Nayak, T. R., Valdovinos, H. F., Myklejord, D. V., Theuer, C. P., Barnhart, T. E., & Cai, W. (2013) · Angiogenesis · doi:10.1007/s10456-013-9344-y · Cited by 29
“The majority of deaths in BC patients are from metastases instead of the primary tumors [2], and studies have shown that BC preferentially metastasizes to the lung, liver, and bones [3].”
Faraj, A. A., Shaik, A. S., Halwani, R., & Alfuraih, A. A. (2015) · Molecular Imaging and Biology · doi:10.1007/s11307-015-0902-0 · Cited by 30
HER2 and uPAR cooperativity contribute to metastatic phenotype of HER2-positive breast cancer
Chandran, V. I., Eppenberger‐Castori, S., Venkatesh, T., Vine, K. L., & Ranson, M. (2015) · Oncoscience · doi:10.18632/oncoscience.146 · Cited by 31
Network motif-based identification of breast cancer susceptibility genes
Zhang, Y., Xuan, J., Reyes, B. G. D. L., Clarke, R. C., & Ressom, H. W. (2008) · Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC) · doi:10.1109/iembs.2008.4650507 · Cited by 29
“ECENT breast cancer studies show that distant metastases are the main cause of death among breast cancer patients [ 1 ].”
BackgroundInfluence of Immune Myeloid Cells on the Extracellular Matrix During Cancer Metastasis
Jiang, D. G., & Lim, S. Y. (2016) · Cancer Microenvironment · doi:10.1007/s12307-016-0181-6 · Cited by 31
Bian, Y., Chang, X., Liao, Y. J., Wang, J., Li, Y., Wang, K., & Wan, X. (2016) · Oncology Reports · doi:10.3892/or.2016.4885 · Cited by 29
Hwang, H., Shin, C., Park, J., Kang, E., Choi, B., Han, J., Do, Y., Ryu, S., & Cho, Y. (2016) · Scientific Reports · doi:10.1038/srep30207 · Cited by 29
Sheets, J. N., Iwanicki, M., Liu, J. F., Howitt, B. E., Hirsch, M. S., Gubbels, J. A. A., Drapkin, R., & Egland, K. A. (2016) · Oncogenesis · doi:10.1038/oncsis.2016.64 · Cited by 31
“Because HGSOC does not require angiogenesis as a means of metastasis, 6,7 whereas breast cancer almost exclusively relies on angiogenesis to metastasize, 36,37 the role of SUSD2 as observed in breast cancer may not manifest any obvious advantage in dissemination in HGSOC.”
BackgroundZeng, F., Ju, R.-J., Liu, L., Xie, H., Mu, L.-M., & Lü, W.-L. (2017) · Pharmacology · doi:10.1159/000480737 · Cited by 29
Ishikawa, M., Osaki, M., Yamagishi, M., Onuma, K., Ito, H., Okada, F., & Endo, H. (2019) · Oncogene · doi:10.1038/s41388-019-0748-z · Cited by 30
Miao, Y., Shen, Q., Zhang, S., Huang, H., Meng, X., Zheng, X. F. S., Yao, Z., He, Z., Lu, S., Cai, C., et al. (2019) · Breast Cancer Research · doi:10.1186/s13058-019-1185-1 · Cited by 31
Hypoxia-mediated changes in bone marrow microenvironment in breast cancer dormancy
Ferrer, A. I., Roser, C. T., El-Far, M. H., Savanur, V. H., Eljarrah, A., Gergues, M., Kra, J., Etchegaray, J., & Rameshwar, P. (2020) · Cancer Letters · doi:10.1016/j.canlet.2020.05.026 · Cited by 32
Guzik, P., Siwowska, K., Fang, H., Cohrs, S., Bernhardt, P., Schibli, R., & Müller, C. (2020) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-020-05054-9 · Cited by 29
Pervaiz, A., Zepp, M., Adwan, H., & Berger, M. R. (2015) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-015-2013-3 · Cited by 33
Mechanisms of Tumor Growth and Metastasis in Head and Neck Squamous Cell Carcinoma
Walsh, J., Lathers, D. M. R., Chi, A. C., Gillespie, M. B., Day, T. A., & Young, M. R. (2007) · Current Treatment Options in Oncology · doi:10.1007/s11864-007-0032-2 · Cited by 29
An Immunotolerant HER-2/neuTransgenic Mouse Model of Metastatic Breast Cancer
Hong, S., Shahverdi, K., Huso, D. L., Wang, Y., Fox, J. J., Hobbs, R. F., Gimi, B., Gabrielson, K. L., Pomper, M. G., Tsui, B. M. W., et al. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-4672 · Cited by 32
Aktaş, G. E., Taştekin, E., & Sarıkaya, A. (2017) · Nuclear Medicine Communications · doi:10.1097/mnm.0000000000000779 · Cited by 29
Current status of autologous breast tumor cell-based vaccines
Kurtz, S. L., Ravindranathan, S., & Zaharoff, D. A. (2014) · Expert Review of Vaccines · doi:10.1586/14760584.2014.969714 · Cited by 28
“In an effort to combat tumor recurrence, approximately 80% of patients receive adjuvant therapy such as chemotherapy [3], hormonal and/or radiotherapy following tumor resection.”
BackgroundD2-40, Podoplanin, and CD31 as a Prognostic Predictor in Invasive Ductal Carcinomas of the Breast
Lee, J. A., Bae, J. W., Woo, S. U., Kim, H., & Kim, C. H. (2011) · Journal of Breast Cancer · doi:10.4048/jbc.2011.14.2.104 · Cited by 28
Li, K., Pan, W., Ma, Y., Xu, X., Gao, Y., He, Y., Wei, L., & Zhang, J. (2019) · Breast Cancer · doi:10.1007/s12282-019-01024-8 · Cited by 28
Management of Brain and Leptomeningeal Metastases from Breast Cancer
Pellerino, A., Internò, V., Mo, F., Franchino, F., Soffietti, R., & Rudà, R. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21228534 · Cited by 29
El‐Senduny, F. F., Altouhamy, M., Zayed, G., Harsha, C., Jalaja, R., Somappa, S. B., Nair, M. S., Kunnumakkara, A. B., Alsharif, F. M., & Badria, F. A.-E. (2021) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2021.102665 · Cited by 28
Nuclear import of PTPN18 inhibits breast cancer metastasis mediated by MVP and importin β2
Wang, T., Ba, X., Zhang, X., Zhang, N., Wang, G., Bai, B., Li, T., Zhao, J., Zhao, Y., Yu, Y. W., et al. (2022) · Cell Death and Disease · doi:10.1038/s41419-022-05167-z · Cited by 28
Pénzes, K., Baumann, C., Szabadkai, I., Őrfi, L., Kéri, G., Ullrich, A., & Torka, R. (2014) · Cancer Biology & Therapy · doi:10.4161/15384047.2014.956634 · Cited by 28
Wang, B., Yan, Y., Zhou, J., Zhou, Q., Gui, S., & Wang, Y. (2013) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2013.03.016 · Cited by 29
Sachdanandam, P. (2008) · BioFactors · doi:10.1002/biof.5520320118 · Cited by 28
Roman, B. I., Coen, L. M. D., Mortier, S. T. F. C., Ryck, T. D., Vanhoecke, B. W. A., KATRITZKY, A. R., Bracke, M., & Stevens, C. V. (2013) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2013.06.048 · Cited by 28
Hardisty, M., Akens, M. K., Hojjat, S., Yee, A., & Whyne, C. M. (2011) · Journal of Orthopaedic Research® · doi:10.1002/jor.22045 · Cited by 28
Pathogenesis of Breast Cancer Metastasis to Brain: a Comprehensive Approach to the Signaling Network
Bahrami, T., & Mehdipour, P. (2014) · Molecular Neurobiology · doi:10.1007/s12035-014-9023-z · Cited by 31
Hauser, A. D., Bergom, C. R., Schuld, N. J., Chen, X., Lorimer, E., Huang, J., Mackinnon, A. C., & Williams, C. L. (2013) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-13-0362 · Cited by 28
FASN, ErbB2-mediated glycolysis is required for breast cancer cell migration
Zhou, L., Jiang, S., Fu, Q., SMITH, K., Tu, K., Li, H., & Zhao, Y. (2016) · Oncology Reports · doi:10.3892/or.2016.4627 · Cited by 28
Unusual roles of caspase-8 in triple-negative breast cancer cell line MDA-MB-231
Blasio, A. D., Fiore, R. D., MORREALE, M., Carlisi, D., Drago‐Ferrante, R., Montalbano, M., Scerri, C. A., TESORIERE, G., & Vento, R. (2016) · International Journal of Oncology · doi:10.3892/ijo.2016.3474 · Cited by 28
van Reesema, L. L. S., Zheleva, V. P., Winston, J. S., Jansen, R. J., O’Connor, C. F., Isbell, A. J., Bian, M., Qin, R., Bassett, P. T., Hinson, V. J., et al. (2016) · EBioMedicine · doi:10.1016/j.ebiom.2016.08.014 · Cited by 28
“Hence, new techniques are needed to select the most effective first-line therapies for breast cancer patients with metastatic diseases to extend their survival (Weigelt et al., 2005; Yap et al., 2012; Gerlinger et al., 2012).”
BackgroundAnti-Invasive and Anti-Proliferative Synergism between Docetaxel and a Polynuclear Pd-Spermine Agent
de Carvalho, A. L. M. B., Medeiros, P. S. C., Costa, F. M., Ribeiro, V. P., Sousa, J. B., Diniz, C., & Marques, M. P. M. (2016) · PLoS ONE · doi:10.1371/journal.pone.0167218 · Cited by 30
Qian, J., Chen, H., Ji, X., Eisenberg, R., Chakravarthy, A. B., Mayer, I. A., & Massion, P. P. (2017) · Scientific Reports · doi:10.1038/srep45828 · Cited by 31
Li, L., Ji, Y., Fan, J., Li, F., Li, Y., Wu, M., Cheng, H., & Xu, C. (2019) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-019-01614-5 · Cited by 29
miRNAs in Health and Disease: A Focus on the Breast Cancer Metastatic Cascade towards the Brain
Sereno, M., Videira, M., Wilhelm, I., Krizbai, I. A., & Brito, M. A. (2020) · Cells · doi:10.3390/cells9081790 · Cited by 29
Stutchbury, T. K., Al‐Ejeh, F., Stillfried, G. E., Croucher, D. R., Andrews, J. L., Irving, D. O., Links, M. J., & Ranson, M. (2007) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-06-0264 · Cited by 28
Valcz, G., Buzás, E. I., Szállási, Z., Kalmár, A., Krenács, T., Tulassay, Z., Igaz, P., & Molnár, B. (2018) · npj Breast Cancer · doi:10.1038/s41523-018-0071-9 · Cited by 27
Cunningham, J. J., Brown, J. S., Vincent, T. L. S., & Gatenby, R. A. (2015) · Evolution Medicine and Public Health · doi:10.1093/emph/eov006 · Cited by 27
Evaluation of the TRIP13 level in breast cancer and insights into potential molecular pathways
Lan, J., Huang, J., Tao, X., Gao, Y., Zhang, L., Huang, W., Luo, J., Liu, C., Deng, Y., Liu, L., et al. (2022) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.17278 · Cited by 28
Nanomedicine Technologies for Diagnosis and Treatment of Breast Cancer
Kitsios, K., Sharifi, S., & Mahmoudi, M. (2023) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.3c00044 · Cited by 28
Zhang, L., Tang, L., Yu, C., Xiao, H., & Liu, C. (2023) · Advanced Functional Materials · doi:10.1002/adfm.202310450 · Cited by 33
The analysis of metastasis in transgenic mouse models
Hüsemann, Y., & Klein, C. A. (2008) · Transgenic Research · doi:10.1007/s11248-008-9225-0 · Cited by 27
Huang, S., Kou, B., Chi, Y., Xi, Y., Cao, Y., Cui, W., Hu, X., Shao, Z., Guo, H., Fu, Y., et al. (2015) · Scientific Reports · doi:10.1038/srep09418 · Cited by 27
Second-harmonic generation scattering directionality predicts tumor cell motility in collagen gels
Burke, K. A., Dawes, R. P., Cheema, M. K., Hove, A. H. V., Benoit, D. S. W., Perry, S. W., & Brown, E. B. (2015) · Journal of Biomedical Optics · doi:10.1117/1.jbo.20.5.051024 · Cited by 27
Increased metastasis with loss of E2F2 in Myc-driven tumors
Yuwanita, I., Barnes, D., Monterey, M. D., O’Reilly, S., & Andrechek, E. R. (2015) · Oncotarget · doi:10.18632/oncotarget.5690 · Cited by 28
Oncologic trogocytosis with Hospicells induces the expression of N-cadherin by breast cancer cells
Poupot, M. (2010) · International Journal of Oncology · doi:10.3892/ijo_00000797 · Cited by 30
Richter, A. M., Walesch, S. K., & Dammann, R. (2016) · Cancers · doi:10.3390/cancers8030026 · Cited by 27
The role of ctDNA detection and the potential of the liquid biopsy for breast cancer monitoring
Openshaw, M. R., Page, K., Fernández-García, D., Guttery, D. S., & Shaw, J. (2016) · Expert Review of Molecular Diagnostics · doi:10.1080/14737159.2016.1184974 · Cited by 27
pH-sensitive pHLIP® coated niosomes
Pereira, M. C., Pianella, M., Wei, D., Moshnikova, A., Marianecci, C., Carafa, M., Andreev, O. A., & Reshetnyak, Y. K. (2016) · Molecular Membrane Biology · doi:10.1080/09687688.2017.1342969 · Cited by 27
Kaiso is highly expressed in TNBC tissues of women of African ancestry compared to Caucasian women
Bassey-Archibong, B. I., Hercules, S. M., Rayner, L. G. A., Skeete, D. H.-A., Connell, S. P. S., Brain, I., Daramola, A. O., Banjo, A. A. F., Byun, J. S., Gardner, K. L., et al. (2017) · Cancer Causes & Control · doi:10.1007/s10552-017-0955-2 · Cited by 31
MicroRNA‑154/ADAM9 axis inhibits the proliferation, migration and invasion of breast cancer cells
Qin, C., Zhao, Y., Gong, C., & Yang, Z. (2017) · Oncology Letters · doi:10.3892/ol.2017.7021 · Cited by 29
“Although great progress has been made in the earlier diagnosis and systemic therapy of patients with breast cancer in recent years, recurrence or distant metastasis continue to present major barriers to the successful treatment of breast cancer (10,11).”
Alipanah, H., Bigdeli, M. R., & Esmaeili, M. A. (2018) · PubMed Central · Cited by 40
Moon, W. K., Chen, I., Yi, A., Bae, M. S., Shin, S. U., & Chang, R. (2018) · Computer Methods and Programs in Biomedicine · doi:10.1016/j.cmpb.2018.05.011 · Cited by 27
Luan, M., Shi, M., Pan, W., Li, N., & Tang, B. (2019) · Chemical Communications · doi:10.1039/c9cc01454c · Cited by 27
Determining the efficacy of dietary phytochemicals in cancer prevention
Manson, M. M., Foreman, B. E., Howells, L. M., & Moiseeva, E. P. (2007) · Biochemical Society Transactions · doi:10.1042/bst0351358 · Cited by 27
Metastatic breast cancer: understanding prognosis and treatment patterns in real-life
Lobbezoo, D. J. A. (2016) · Research Publications (Maastricht University) · doi:10.26481/dis.20161110dl · Cited by 27
Guo, X., Yu, K. G., & Huang, R. (2024) · Molecular Oral Microbiology · doi:10.1111/omi.12446 · Cited by 27
Kim, G., Kim, N. I., Lee, J. S., Park, M. H., & Yoon, J. H. (2016) · Applied immunohistochemistry & molecular morphology · doi:10.1097/pai.0000000000000323 · Cited by 26
Yang, J., Wu, N.-N., Huang, D., Luo, Y.-C., Huang, J., He, H.-Y., Lu, H., & Song, W. (2017) · Tumor Biology · doi:10.1177/1010428317713492 · Cited by 26
Neutrophil-Derived Interleukin 16 in Premetastatic Lungs Promotes Breast Tumor Cell Seeding
Donati, K., Sépult, C., Rocks, N., Blacher, S., Gerard, C. M., Noël, A., & Cataldo, D. D. (2017) · Cancer Growth and Metastasis · doi:10.1177/1179064417738513 · Cited by 29
Zeng, L., Deng, X., Zhong, J., Li, Y., Tao, X., Zhang, S., Zeng, Y., He, G., Tan, P., & Tao, Y. (2019) · BMC Cancer · doi:10.1186/s12885-019-6016-3 · Cited by 26
Qi, J., He, J., Liu, C.-B., Jin, S.-M., Yang, X., Bai, H., & Ma, Y. (2021) · Genes & Diseases · doi:10.1016/j.gendis.2021.03.008 · Cited by 28
“Although surgery is an effective treatment for breast cancer, increased circulating tumor cell-mediated metastasis enhances the risks of tumor recurrence and therapy failure.(4) Therefore, it is essential to understand tumorigenesis and develop novel therapy combinations for breast cancer.”
Metadata
- Authors
- Weigelt, B., Peterse, J. L., & van't Veer, L. J.
- Affiliations
- The Netherlands Cancer Institute (NL)
- ORCID
- Weigelt, Britta
- Venue
- Nature Reviews Cancer
- Published
- 2005-08-01
- Volume
- 5
- Issue
- 8
- Pages
- 591-602
- ISSN
- 1474-175X (ISSN-L)
- 1474-1768
- OpenAlex
- W2004280628
- Semantic Scholar
- 3bd1490d7b6c8daa59bd35260c6c71e39d3d62fa
- Cited by
- 2,232
- References
- 112
- Citations by year
- 2026: 34 · 2025: 69 · 2024: 90 · 2023: 111 · 2022: 139 · 2021: 154 · 2020: 159 · 2019: 147 · 2018: 140 · 2017: 191 · 2016: 162 · 2015: 152 · 2014: 121 · 2013: 104 · 2012: 88
- FWCI
- 5.73
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature reviews. Cancer (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Breast Cancer Treatment Studies
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mechanisms of cancer metastasis
- Keywords
- breast cancer, metastasis, prognostic factors, metastatic potential, lymph node metastasis, distant metastasis, carcinogenesis, DNA microarrays, systemic disease, metastasis model
- MeSH terms
- Breast Neoplasms, Female, Humans, Neoplasm Metastasis, Biomarkers, Tumor, Models, Animal
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.